
The First FDA Approved Treatment for Metastatic Uv...
On January 26, 2022, the U.S. Food and Drug Administration announced the approval of KIMMTRAK (tebentafusp-tebn), the first and only FDA-approved treatment for metastatic u...
Learn more about our upcoming Galas and Signature Events Learn More
Guest blog post by Ian Michael Crumm, Celebrity Esthetician, Podcast Host, Key Opinion Leader, Melanoma Advocate and 2025 #GetNaked Spokesperson: Some moments stick with yo...
On January 26, 2022, the U.S. Food and Drug Administration announced the approval of KIMMTRAK (tebentafusp-tebn), the first and only FDA-approved treatment for metastatic u...
Guest blog post by Kristin R. McJunkins, Stage III melanoma survivor and advocate: In 2008 when I was 38 years old, I was diagnosed with Stage IIIa cutaneous melanoma. Afte...
Guest blog post by Keith T. Flaherty, MD, Associate Professor of Medicine at Harvard Medical School, Director of Developmental Therapeutics at Massachusetts General Hospita...
The MRF is proud to share the following press release from the Congressionally Directed Medical Research Program announcing MRF Board Chair (and melanoma survivor) Doug Bro...
Guest blog post by Martin McMahon, PhD, Senior Director of Preclinical Research, Principal Investigator at Huntsman Cancer Institute. Dr. McMahon received the Diana Ashby S...
Guest blog post by Richard K. Lodwick, OD: As I explain to most every patient, the view into the eye is a direct view into the body. Within the eye we have access to nerves...
Guest blog post by ocular melanoma patient and advocate Karen Kaludov: When I was in college, a doctor told me my goal was to not get skin cancer before I was 40. The docto...
Guest blog post by ocular melanoma survivor and advocate Sara Haven Rusch: I got lucky. In 2016 I was 8 months pregnant. I went to a routine eye exam in order toÂ...
Washington, DC (November 2) – The Melanoma Research Foundation, the largest independent organization devoted to melanoma, today announced that it will be acquiring the Ch...
Guest blog post by Vernon K. Sondak, MD (Department of Cutaneous Oncology, Moffitt Cancer Center), with Jane L. Messina, MD (Departments of Cutaneous Oncology and Anatomic ...
Guest blog post by Elena Hawryluk, MD, PhD, pediatric dermatologist at Boston Children’s Hospital and member of the MRF’s Pediatric Melanoma Scientific Steering...
Guest blog post by Vernon K. Sondak, MD (Department of Cutaneous Oncology, Moffitt Cancer Center), with Jane L. Messina, MD (Departments of Cutaneous Oncology and Anatomic ...